Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis
Abstract
Successful treatment of hepatitis C reduces liver inflammation and fibrosis; however, patients remain at risk of developing hepatocellular carcinoma (HCC).
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Apr 20, 2023
- Source ID
- 10.1002/cam4.5711
Entities
People
- Alex S Bowman
- Andrea D. Branch
- Ashley E. Stueck
- Chiara Rocha
- Erin H. Doyle
- James F. Crismale
- Jasnit Makkar
- Kian Bichoupan
- Myron Schwartz
- M‐isabel Fiel
- Neal Patel
- Nicolas Goossens
- Ponni V. Perumalswami
- Sara Lewis
- Thomas D. Schiano
- Yujin Hoshida
Organizations
- Cancer Prevention and Research Institute of Texas
- Columbia University
- Dalhousie University
- European Commission
- Icahn School of Medicine at Mount Sinai
- Irma T. Hirschl Trust
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute on Drug Abuse
- Nuvance Health
- Prevent Cancer Foundation
- United States Department of Defense
- University of Michigan
- University of Texas at Austin